CHF 42.54 intraday drop Feb 2026: BMY.SW Bristol-Myers Squibb (SIX) bounce
The stock opened at CHF 42.54 and trades down -4.40% intraday on 23 Feb 2026, putting BMY.SW stock in an oversold setup we are watching for a short rebound. Volume is 500.00 shares versus an average of 22.00 shares, giving a relative volume of 22.73 and signalling a sharp intraday reaction. Fundamentals remain mixed: EPS is 2.66 and reported PE is 15.99, while the healthcare sector shows modest 3-month strength. Meyka AI, as an AI-powered market analysis platform, flags the move as an oversold bounce candidate but stresses careful risk control.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
